A PMHNP working in a state psychiatric hospital is approached by a research team seeking to enroll her patients with chronic schizophrenia in a clinical trial for a new antipsychotic. Participants would be randomized to the new drug or placebo, requiring a washout of current antipsychotic medication. The researchers offer each participant $500 compensation. Several patients express interest in participating. The PMHNP considers the ethical issues involved.